Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.
about
The provision of NHS health checks in a community setting: an ethnographic account.Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in EnglandEngaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.Making a success of providing NHS Health Checks in community pharmacies across the Tees Valley: a qualitative studyCardiovascular screening in general practice in a low SES area.The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy settingThe roles of community pharmacists in cardiovascular disease prevention and management.Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional studyExperiences of patients and healthcare professionals of NHS cardiovascular health checks: a qualitative studyScreening for major diseases in community pharmacies: a systematic review.Inequity in cardiovascular care in the English National Health Service (NHS): a scoping review of the literature.Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar.A community pharmacy-based cardiovascular risk screening service implemented in IranNear-patient testing in primary care.One year follow-up of patients with screen-detected metabolic syndrome in primary care: an observational study.Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme.Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study.Community pharmacy COPD services: what do researchers and policy makers need to know?Intervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease risk.Development of a Blended Learning Environment to Support Achievement of Graduate Outcomes through Optimal Learning in an Undergraduate Pharmacy Course
P2860
Q27307078-294E035D-35BF-4CAA-934B-E46AD9E0654DQ30596917-86377307-988F-4D44-9C35-DAF043843994Q33685028-ED81BE4F-93A8-4A5F-9774-610ACD2B9CAEQ34022355-E1DA6CFA-E2EA-4E4A-A8E9-0E1DCC6872C6Q34507659-0AECB565-AB01-4B45-A065-36ACB5F0A49CQ35137431-9541900A-0995-4560-BB46-007EB3800F71Q36583618-AD27345F-3D4F-4F61-BBE5-41723BCDA531Q36732846-4D437617-C631-428F-BBC7-635A1E499B14Q37353432-26AB4E76-BC92-4E32-8A14-B23EBBD6209CQ38107551-13283E58-EBAB-4CD5-95B4-01C12AA82E87Q38409844-AB97AA16-E919-4100-BF99-081CF4CD08D1Q38629187-6477D120-227D-4CEF-A1AA-7FC26EF9C34EQ38687368-56C83E5D-CF25-4E05-9DD6-95ED5C60BC45Q42906379-1009053C-6653-4B2D-817F-978F283F9BC0Q43470085-A232AA0D-58F6-4A89-83E2-8641963CEB61Q45104358-6AC9639E-4577-4AA7-9362-8E207BBC48B3Q48524602-1913A291-6201-494F-B41A-93D21150FD69Q49303616-8FD1E385-AF28-435E-A42D-D36DCD59B649Q50241717-C953CA1B-E8DE-4BDA-BE7D-C3623587DB37Q58979342-F8896C20-0264-4CA1-9AA6-1C675E993395
P2860
Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Evaluation of a cardiovascular ...... vice) in community pharmacies.
@en
Evaluation of a cardiovascular disease opportunistic risk assessment pilot
@nl
type
label
Evaluation of a cardiovascular ...... vice) in community pharmacies.
@en
Evaluation of a cardiovascular disease opportunistic risk assessment pilot
@nl
prefLabel
Evaluation of a cardiovascular ...... vice) in community pharmacies.
@en
Evaluation of a cardiovascular disease opportunistic risk assessment pilot
@nl
P356
P1476
Evaluation of a cardiovascular ...... vice) in community pharmacies.
@en
P2093
J M P Horgan
R J McManus
P304
P356
10.1093/PUBMED/FDP092
P577
2009-10-28T00:00:00Z